Vilanterol Glycopyrronium Fluticasone Furoate Inhaler Exporter from India
Cordium Pharmaceuticals Pvt. Ltd. offers pharmaceutical sourcing and international export support for respiratory medicines, including Vilanterol + Glycopyrronium + Fluticasone Furoate inhalation formulations, subject to applicable registration, prescription and import requirements in the destination market.
This triple-therapy combination brings together a LABA (vilanterol), LAMA (glycopyrronium), and inhaled corticosteroid (fluticasone furoate) in one respiratory treatment concept.
Product SKU
VIL-GLY-FF-INH
Generic Composition
Vilanterol + Glycopyrronium + Fluticasone Furoate
Therapeutic Category
Respiratory Medicine | Triple Inhaled Therapy | ICS + LABA + LAMA
What Is Vilanterol + Glycopyrronium + Fluticasone Furoate Inhaler?
Vilanterol + Glycopyrronium + Fluticasone Furoate is a fixed-dose triple inhaled combination designed to provide three complementary pharmacological actions:
Vilanterol – LABA: helps relax airway smooth muscle and improve airflow.
Glycopyrronium – LAMA: provides long-acting muscarinic receptor blockade, helping maintain airway relaxation.
Fluticasone Furoate – ICS: reduces airway inflammation.
Together, the three components target airway narrowing and airway inflammation through complementary mechanisms.
Clinical research has evaluated VIL/GLY/FF triple therapy in persistent asthma, with phase-3 studies reporting non-inferiority to an active comparator and generally comparable tolerability. These findings should not be interpreted as approval for every country or every indication.
Uses of Vilanterol + Glycopyrronium + Fluticasone Furoate Inhaler
Depending on the specific formulation, registration and local prescribing information, this combination may be investigated or used for maintenance treatment of obstructive airway diseases such as asthma or COPD.
It is intended as maintenance therapy rather than an emergency rescue treatment.
Patients should use the product only according to the prescribing information and advice of a qualified healthcare professional.
Advantages of Triple Therapy Inhaler
1. Three complementary mechanisms
The combination provides an ICS + LABA + LAMA approach in a single inhaled treatment.
2. Bronchodilation plus anti-inflammatory action
Vilanterol and glycopyrronium help maintain airway relaxation, while fluticasone furoate addresses airway inflammation.
3. Convenient treatment concept
Combining three respiratory medicines into one inhaler may simplify treatment compared with using multiple separate inhalers, where appropriate.
4. Long-acting components
Vilanterol and glycopyrronium are long-acting bronchodilators. GSK's pharmacology information describes approximately 24-hour duration for both molecules.
5. Potential adherence advantage
A single inhaler can reduce the complexity associated with multiple inhaler devices.
Disadvantages, Precautions & Important Safety Information
This is a prescription respiratory medicine and should be used under appropriate medical supervision.
Possible adverse effects can vary according to the exact formulation and patient.
Potential issues associated with the individual components or triple therapy may include:
Headache
Upper respiratory tract infection
Sore throat
Hoarseness
Oral or throat fungal infection (thrush)
Cough
Palpitations or increased heart rate
Tremor
Urinary retention
Eye-related effects such as increased intraocular pressure
Possible pneumonia risk associated with inhaled corticosteroid therapy in susceptible COPD patients
Hypersensitivity or allergic reactions
Patients should follow the product-specific prescribing information. Inhaled corticosteroid-containing therapy may increase the risk of oral candidiasis; rinsing the mouth after use can help reduce this risk.
Important: This type of maintenance inhaler should not automatically be considered a substitute for a rescue inhaler during sudden breathing difficulty. The appropriate rescue medication should be determined by the treating clinician.
Who May Consider This Treatment?
Vilanterol + Glycopyrronium + Fluticasone Furoate triple therapy may be relevant to healthcare professionals managing patients with persistent obstructive airway disease where an ICS + LABA + LAMA treatment strategy is clinically appropriate.
The exact indication, strength, device, age group, prescription status and availability differ between countries.
Always verify local regulatory approval before importing, marketing, prescribing or distributing the product.
Vilanterol Glycopyrronium Fluticasone Furoate Inhaler Export from India
Cordium Pharmaceuticals Pvt. Ltd. supports international pharmaceutical sourcing and export enquiries from India for eligible respiratory products.
We can assist with enquiries from:
Singapore
Target locations: Singapore, Jurong, Woodlands, Tampines, Bedok, Yishun
Malaysia
Target locations: Kuala Lumpur, Petaling Jaya, Shah Alam, Johor Bahru, Penang, George Town
Kenya
Target locations: Nairobi, Mombasa, Kisumu, Nakuru, Eldoret
United States
Target locations: New York, Los Angeles, Chicago, Houston, Dallas, Miami, Boston
United Kingdom
Target locations: London, Birmingham, Manchester, Liverpool, Leeds, Glasgow
United Arab Emirates
Target locations: Dubai, Abu Dhabi, Sharjah, Ajman, Al Ain
South Africa
Target locations: Johannesburg, Cape Town, Durban, Pretoria, Gqeberha
Availability and exportability depend on the destination country's regulatory and import requirements.
Why Choose Cordium Pharmaceuticals?
Trusted Indian Pharmaceutical Export Partner
Cordium Pharmaceuticals Pvt. Ltd. provides international pharmaceutical sourcing and export support from India.
Global Buyer Support
We work with international pharmaceutical buyers, distributors, healthcare businesses and eligible import partners.
Product-Focused Sourcing
Our focus includes respiratory, dermatology, gastro, allergy and other pharmaceutical categories.
Export Documentation Support
Subject to the destination market and product, we can coordinate appropriate commercial and pharmaceutical documentation required for export transactions.
International Enquiry Support
We communicate with overseas buyers regarding product availability, specifications, packaging, commercial requirements and shipment coordination.
Quality & Compliance Focus
Product selection and international supply should be based on applicable manufacturing, quality, registration and destination-market requirements.
Enquire About Vilanterol + Glycopyrronium + Fluticasone Furoate Inhaler
Cordium Pharmaceuticals Pvt. Ltd.
WhatsApp: +91-9405117673
Email: info@cordiumpharma.com